Many ASX companies spend $20–25k per month on investor media and distribution platforms. But impressions don’t equal impact. Here’s how boards are reassessing ROI.

Biotech progress, capital, and investor attention rarely move in straight lines. Understanding this non linear reality is key to navigating ASX biotech market cycles.

As investor relations strategies are increasingly stress-tested, a clear pattern is emerging in how well-prepared ASX companies are responding. Here are the disciplines that distinguish them.

As markets become more selective, ASX boards are stress-testing investor relations strategies around capital alignment, messaging consistency and disclosure discipline. Here’s where pressure is emerging first.

ASX boards are quietly reassessing capital access, messaging consistency and adviser alignment as market conditions tighten. Here’s what’s changing - and why it matters.

When Media Narratives Move Markets: What the AFR’s Kyle & Jackie O Story Reveals About ASX Media Investor Relations.

The article on ARN and Kyle & Jackie O in The Australian Financial Review by Sam Buckingham-Jones confuses entertainment headlines with capital markets reality.

By linking Kyle & Jackie O’s contract to ARN’s share price and corporate challenges makes for an entertaining read, but it’s not an accurate one.

29 July: Is your story resonating with the market? In a world of noise, clarity wins. We help listed companies craft investor communications that don’t just inform — they influence. From strategic messaging to market-moving narratives, we work with leadership teams to ensure your story is heard by the right people, at the right time, in the right way.